Advertisement

Pneumo News

, Volume 11, Issue 3, pp 32–40 | Cite as

Gut therapierbar und trotzdem oft übersehen

Chronisch thromboembolische pulmonale Hypertonie

  • Franziska C. Trudzinski
  • Heinrike WilkensEmail author
fortbildung
  • 13 Downloads

Der klinische Verlauf einer Lungenembolie kann nur schwer vorhergesagt werden, er reicht vom plötzlichen Tod bis zur vollständigen Wiederherstellung. Die schwerste Folge ist die chronisch thromboembolische pulmonale Hypertonie, die leider oft übersehen oder falsch klassifiziert wird. Das kann dazu führen, dass Patienten nicht oder erst spät einer der drei zur Verfügung stehenden Therapieoptionen zugeführt werden.

Literatur

  1. 1.
    Simonneau G, Montani D, Celermajer DS et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1);  https://doi.org/10.1183/13993003.01913-2018CrossRefGoogle Scholar
  2. 2.
    Kim NH, Delcroix M, Jais X et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(1);  https://doi.org/10.1183/13993003.01915-2018CrossRefGoogle Scholar
  3. 3.
    Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. 2017;49(2);  https://doi.org/10.1183/13993003.01792-2016CrossRefGoogle Scholar
  4. 4.
    Kramm T, Wilkens H, Fuge J et al. Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany. Clin Res Cardiol. 2018;107(7):548–53CrossRefGoogle Scholar
  5. 5.
    Guerin L, Couturaud F, Parent F et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost. 2014;112(3):598–605CrossRefGoogle Scholar
  6. 6.
    Klok FA, van der Hulle T, den Exter PL et al. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev. 2014;28(6):221–6CrossRefGoogle Scholar
  7. 7.
    Pepke-Zaba J, Delcroix M, Lang I et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124(18):1973–81CrossRefGoogle Scholar
  8. 8.
    Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J. 2000;15(3):440–8CrossRefGoogle Scholar
  9. 9.
    Bonderman D, Turecek PL, Jakowitsch J et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003;90(3):372–6CrossRefGoogle Scholar
  10. 10.
    Bonderman D, Wilkens H, Wakounig S et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33(2):325–31CrossRefGoogle Scholar
  11. 11.
    Dorfmuller P, Gunther S, Ghigna MR et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J. 2014;44(5):1275–88CrossRefGoogle Scholar
  12. 12.
    Humbert M, Guignabert C, Bonnet S et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53(1);  https://doi.org/10.1183/13993003.01887-2018CrossRefGoogle Scholar
  13. 13.
    Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103(3):685–92CrossRefGoogle Scholar
  14. 14.
    Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81(2):151–8CrossRefGoogle Scholar
  15. 15.
    Held M, Kolb P, Grun M et al. Functional Characterization of Patients with Chronic Thromboembolic Disease. Respiration. 2016;91(6):503–9CrossRefGoogle Scholar
  16. 16.
    Pfeuffer E, Krannich H, Halank M et al. Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH. Lung. 2017;195(6):759–68CrossRefGoogle Scholar
  17. 17.
    Ivarsson B, Sjoberg T, Hesselstrand R et al. Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. ERJ Open Res. 2019;5(1);  https://doi.org/10.1183/23120541.00218-2018CrossRefGoogle Scholar
  18. 18.
    Galie N, Humbert M, Vachiery JL et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119CrossRefGoogle Scholar
  19. 19.
    Wilkens H, Konstantinides S, Lang IM et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:69–78CrossRefGoogle Scholar
  20. 20.
    Frost A, Badesch D, Gibbs JSR et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53(1);  https://doi.org/10.1183/13993003.01904-2018CrossRefGoogle Scholar
  21. 21.
    Tunariu N, Gibbs SJ, Win Z et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007;48(5):680–4CrossRefGoogle Scholar
  22. 22.
    Cannon JE, Su L, Kiely DG et al. Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort. Circulation. 2016;133(18):1761–71CrossRefGoogle Scholar
  23. 23.
    Wiedenroth CB, Olsson KM, Guth S et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease. Pulm Circ. 2018;8(1):2045893217753122CrossRefGoogle Scholar
  24. 24.
    Ejiri K, Ogawa A, Fujii S et al. Vascular Injury Is a Major Cause of Lung Injury After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension. Circ Cardiovasc Interv. 2018;11(12):e005884CrossRefGoogle Scholar
  25. 25.
    Ghofrani HA, D'Armini AM, Grimminger F et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369(4):319–29CrossRefGoogle Scholar
  26. 26.
    Simonneau G, D'Armini AM, Ghofrani HA et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J. 2015;45(5):1293–302CrossRefGoogle Scholar
  27. 27.
    Simonneau G, D'Armini AM, Ghofrani HA et al. Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial. Lancet Respir Med. 2016;4(5):372–80CrossRefGoogle Scholar
  28. 28.
    Marra AM, Halank M, Benjamin N et al. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study). Respir Res. 2018;19(1):258CrossRefGoogle Scholar
  29. 29.
    Ghofrani HA, Simonneau G, D'Armini AM et al. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. Lancet Respir Med. 2017;5(10):785–94CrossRefGoogle Scholar
  30. 30.
    Konstantinides SV, Torbicki A, Agnelli G et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–69, 3069a-3069kCrossRefGoogle Scholar
  31. 31.
    Klok FA, Surie S, Kempf T et al. A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res. 2011;128(1):21–6CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Klinik für Innere Medizin V, Pneumologie, Allergologie, IntensivmedizinUniversitätsklinikum des SaarlandesHomburg/SaarDeutschland

Personalised recommendations